References
- Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE. Psychostimulant-like effects of p-fluoroamphetamine in the rat. Eur J Pharmacol 1995; 287:105–113.
- McElroy JF, Miller JM, Meyer JS. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action. J Pharmacol Exp Ther 1984; 228:593–599.
- Fuller RW, Baker JC, Perry KW, Molloy BB. Comparison of 4-chloro-, 4-bromoand 4-fluoroamphetamine in rats: drug levels in brain and effects on brain serotonin metabolism,Neuropharmacology 1975; 14:739–746.
- Nagai F, Nonaka R, Satoh Hisashi Kamimura K. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 2007; 559:132–137.
- Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB. In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat. J Pharmacol Exp Ther 2011; 337:218–225.
- Europol drugs newsletter 2009. Alert 2009–001, Project SYNERGY,4-fluoroamphetamine (EDOCF403292) 1. July 1–9.
- United Nations Office on Drugs and Crime, Details for Phenethylamines, UNODC.org website ©2014 UNODC: https://www.unodc.org/LSS/SubstanceGroup/Details/275dd468-75a3-4609-9e96-cc5a2f0da467 (Last access April 10 2014).
- Brunt TM, Koeter MW, Niesink RJ, van den Brink W. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology (Berl) 2012; 220:751–762.
- Rust KY, Baumgartner MR, Dally AM, Kraemer T. Prevalence of new psychoactive substances: a retrospective study in hair. Drug Test Anal 2012; 4:402–408.
- Chen JP. Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm. J Invasive Cardiol 2007; 19:E89–E92.
- Yeo KK, Wijetunga M, Ito H, Efird JT, Tay K, Seto TB, et al. The association of methamphetamine use and cardiomyopathy in young patients. Am J Med 2007; 120:165–171.
- Hung MJ, Kuo LT, Cherng WJ. Amphetamine-related acute myocardial infarction due to coronary artery spasm. Int J Clin Pract 2003; 57:62–64.
- Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007; 102:1204–1211.
- Dande AS, Fisher LI, Warshofsky MK. Inverted takotsubo cardiomyopathy. J Invasive Cardiol 2011; 23:E76–E78.
- Movahed MR, Mostafizi K. Reverse or inverted left ventricular apical ballooning syndrome (reverse Takotsubo cardiomyopathy) in a young woman in the setting of amphetamine use. Echocardiography 2008; 25:429–432.
- Subramaniam A, Cooke JC, Ernest D.“Inverted” tako-tsubo cardiomyopathy due to exogenous catecholamines. Crit Care Resusc 2010; 12:104–108.
- Srikanth S, Barua R, Ambrose J. Methamphetamine-associated acute left ventricular dysfunction: a variant of stress-induced cardiomyopathy. Cardiology 2008; 109:188–192.
- Saiful FB, Lafferty J, Jun CH, Teli S, Duvvuri S, Khattri S, Bhat T. Takotsubo cardiomyopathy due to iatrogenic methadone withdrawal. Rev Cardiovasc Med 2011; 12:164–167.
- Spadotto V, Zorzi A, Elmaghawry M, Meggiolaro M, Pittoni GM. Heart failure due to ‘stress cardiomyopathy’: a severe manifestation of the opioid withdrawal syndrome. Eur Heart J Acute Cardiovasc Care 2013; 2:84–87.
- Alkermes® and Vivitrol® Vivitrol package information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021897s005s010lbl.pdf. Accessed July 2014.
- Röhrich J, Becker J, Kaufmann T, Zörntlein S, Urban R. Detection of the synthetic drug 4-fluoroamphetamine (4-FA) in serum and urine. Forensic Sci Int 2012; 215:3–7.
- Johansen SS, Hansen TM. Isomers of fluoroamphetamines detected in forensic cases in Denmark. Int J Legal Med 2012; 126: 541–547.
- Huang KL, Shaw KP, Wang D, Hsu K, Huang TS, Chen HI. Free radicals mediate amphetamine-induced acute pulmonary edema in isolated rat lung. Life Sci 2002; 71:1237–1244.
- Menon V, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol 2003; 92:368–372.
- Sutter ME, Gaedigk A, Albertson TE, Southard J, Owen KP, Mills LD, Diercks DB. Polymorphisms in CYP2D6 may predict methamphetamine related heart failure. Clin Toxicol (Phila) 2013; 51:540–544.